It is tempting to speculate that ACE2 activator, DIZE, provides potentially a novel therapeutic approach to the treatment/prevention of atherosclerosis and fatty liver diseases by influencing macrophages polarization and taurine biosynthesis. Here, ACE2 is linked to fatty liver disease.